Dai, M., Freeman, B., Bruno, F. P., Shikani, H. J., Tanowitz, H. B., Weiss, L. M., . . . Desruisseaux, M. S. (2012). The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.

Dai, Minxian, Brandi Freeman, Fernando P. Bruno, Henry J. Shikani, Herbert B. Tanowitz, Louis M. Weiss, Sandra E. Reznik, Ralph A. Stephani, and Mahalia S. Desruisseaux. The Novel ETA Receptor Antagonist HJP-272 Prevents Cerebral Microvascular Hemorrhage in Cerebral Malaria and Synergistically Improves Survival in Combination With an Artemisinin Derivative. 2012.

Dai, Minxian, et al. The Novel ETA Receptor Antagonist HJP-272 Prevents Cerebral Microvascular Hemorrhage in Cerebral Malaria and Synergistically Improves Survival in Combination With an Artemisinin Derivative. 2012.